Totality outcome of afatinib sequential treatment in patients with EGFR mutation-positive non-small cell lung cancer in South Korea (TOAST): Korean Cancer Study Group (KCSG) LU-19-22.
TRANSLATIONAL LUNG CANCER RESEARCH（2022）
摘要
This study showed that sequential approach of afatinib followed by second line treatment is an effective therapeutic strategy for M+ NSCLC patients.
更多查看译文
关键词
Non-small cell lung cancer (NSCLC),afatinib,epidermal growth factor receptor (EGFR),sequential treatment,tyrosine kinase inhibitor (TKI)
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要